Harry F. Bradford

Harry F. Bradford's AcademicInfluence.com Rankings

Harry F. Bradford

Biology

#8618

World Rank

#11723

Historical Rank

Neuroscience

#1203

World Rank

#1247

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Harry F. Bradford Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Harry F. Bradford's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Glutamate, GABA and epilepsy (1995) (449)
GLUTAMINE—A MAJOR SUBSTRATE FOR NERVE ENDINGS (1978) (370)
Glutamate Release in Experimental Ischaemia of the Retina: An Approach Using Microdialysis (1992) (256)
METABOLISM OF BEDS OF MAMMALIAN CORTICAL SYNAPTOSOMES: RESPONSE TO DEPOLARIZING INFLUENCES (1972) (211)
On glutaminase activity in mammalian synaptosomes (1976) (191)
The kindled amygdala model of epilepsy: anticonvulsant action of amino acid antagonists (1983) (177)
Biochemical evidence for the presence of presynaptic receptors on dopaminergic nerve terminals (1978) (169)
RESPIRATION IN VITRO OF SYNAPTOSOMES FROM MAMMALIAN CEREBRAL CORTEX (1969) (164)
METABOLISM OF GLUCOSE AND GLUTAMATE BY SYNAPTOSOMES FROM MAMMALIAN CEREBRAL CORTEX (1969) (141)
AMINO ACIDS IN SYNAPTIC VESICLES FROM MAMMALIAN CEREBRAL CORTEX: A REAPPRAISAL (1973) (135)
DEPOLARIZING STIMULI AND THE RELEASE OF PHYSIOLOGICALLY ACTIVE AMINO ACIDS FROM SUSPENSIONS OF MAMMALIAN SYNAPTOSOMES (1973) (132)
Metabolic response of synaptosomes to electrical stimulation: release of amino acids. (1970) (130)
Glutamine and Glucose as Precursors of Transmitter Amino Acids: Ex Vivo Studies (1983) (129)
Co-release of glutamate and aspartate from cholinergic and GABAergic synaptosomes (1987) (123)
Stimulation and solubilization of the sodium ion-activated adenosine triphosphatase of cerebral microsomes by surface-active agents, especially polyoxyethylene ethers: actions of phospholipases and a neuraminidase. (1964) (120)
Excitatory Amino Acid Neurotransmitters in the Corticostriate Pathway: Studies Using Intracerebral Microdialysis In Vivo (1986) (115)
Actions of Tremorgenic Fungal Toxins on Neurotransmitter Release (1980) (114)
Specific release of endogenous glutamate from piriform cortex stimulated in vitro (1976) (113)
The inhibitory effect of sodium n‐dipropyl acetate on the degradative enzymes of the GABA shunt (1975) (113)
Modulation of neurotransmitter release induced by brain-derived neurotrophic factor in rat brain striatal slices in vitro (2002) (112)
PATTERNS OF AMINO ACID RELEASE FROM NERVE‐ENDINGS ISOLATED FROM SPINAL CORD AND MEDULLA (1973) (107)
Inhibition of the development of electrical kindling of the prepyriform cortex by daily focal injections of excitatory amino acid antagonists. (1988) (106)
ON THE SITE OF ORIGIN OF TRANSMITTER AMINO ACIDS RELEASED BY DEPOLARIZATION OF NERVE TERMINALS IN VITRO (1977) (105)
In Vivo Release from Cerebral Cortex of [14C]Glutamate Synthesized from [U‐14C]Glutamine (1983) (89)
Potentiation by Kainate of Excitatory Amino Acid Release in Striatum: Complementary In Vivo and In Vitro Experiments (1988) (85)
IONIC BASIS FOR THE DEPOLARIZATION OF CEREBRAL TISSUES BY EXCITATORY ACIDIC AMINO ACIDS (1966) (82)
Presynaptic Control of the Synthesis and Release of Dopamine from Striatal Synaptosomes: A Comparison Between the Effects of 5‐Hydroxytryptamine, Acetylcholine, and Glutamate (1980) (82)
Effect of Amygdaloid Kindling on the Content and Release of Amino Acids from the Amygdaloid Complex: In Vivo and In Vitro Studies (1995) (82)
Is Glutamate a Trigger Factor in Epileptic Hyperactivity? (1981) (78)
Kindling of full limbic seizures by repeated microinjections of excitatory amino acids into the rat amygdala (1989) (75)
Common Anticonvulsants Inhibit Ca2+ Uptake and Amino Acid Neurotransmitter Release In Vitro (1987) (70)
Signalling pathways involved in the short-term potentiation of dopamine release by BDNF (2003) (70)
Inhibitory actions of opioid compounds on calcium fluxes and neurotransmitter release from mammalian cerebral cortical slices (1986) (70)
Current views of the pathobiochemistry of epilepsy. (1987) (70)
Anti-epileptogenic and anticonvulsant activity of l-2-amino-4-phosphonobutyrate, a presynaptic glutamate receptor agonist (1997) (70)
The controlled conversion of human neural progenitor cells derived from foetal ventral mesencephalon into dopaminergic neurons in vitro. (2002) (70)
The stimulus‐induced release of acetylcholine from synaptosome beds and its calcium dependence (1972) (70)
N‐Methyl‐D‐Aspartate Releases Excitatory Amino Acids in Rat Corpus Striatum In Vivo (1991) (69)
Release of amino acids from the maturing cobalt-induced epileptic focus (1976) (66)
Anticonvulsant action of amino acid antagonists against kindled hippocampal seizures (1984) (66)
Release of amino acids from chronic epileptic and sub-epileptic foci in vivo (1980) (64)
Isolated Nerve Terminals as an In Vitro Preparation for the Study of Dynamic Aspects of Transmitter Metabolism and Release (1975) (63)
The stimulatory effect of brain-derived neurotrophic factor on dopaminergic phenotype expression of embryonic rat cortical neurons in vitro. (1994) (63)
The response of human and rat fetal ventral mesencephalon in culture to the brain-derived neurotrophic factor treatment (1994) (63)
Tetanus toxin inhibits amino acid release from nerve endings in vitro. (1973) (63)
Effect of Cortico‐Striate Pathway Lesion on the Activities of Enzymes Involved in Synthesis and Metabolism of Amino Acid Neurotransmitters in the Striatum (1985) (63)
The BDNF content of postnatal and adult rat brain: the effects of 6-hydroxydopamine lesions in adult brain. (1996) (62)
Relative activities of glutamine synthetase and glutaminase in mammalian synaptosomes (1979) (61)
Anticonvulsant and glutamate release-inhibiting properties of the highly potent metabotropic glutamate receptor agonist (2S,2′R,3′R)-2-(2′,3′-dicarboxycyclopropyl)glycine (DCG-IV) (1998) (61)
Blockade of both epileptogenesis and glutamate release by (1S,3S)-ACPD, a presynaptic glutamate receptor agonist (1995) (61)
Evidence for presynaptic cholinergic receptors on dopaminergic terminals: Degeneration studies with 6-hydroxydopamine (1979) (61)
Continuous glutamate leakage from brain cells is balanced by compensatory high-affinity reuptake transport (1987) (59)
The synaptosome: An isolated, working, neuronal compartment (1973) (54)
Specific group II metabotropic glutamate receptor activation inhibits the development of kindled epilepsy in rats (1998) (53)
The Effects of Scorpion Venom Toxin on the Release of Amino Acid Neurotransmitters from Cerebral Cortex In Vivo and In Vitro (1980) (53)
Differential amino acid neurotransmitter release in rat neostriatum following lesioning of the cortico-striatal pathway (1982) (52)
NMDA receptor blockade inhibits glutamate-induced kindling of the rat amygdala (1990) (52)
Co-release of acetylcholine, glutamate and taurine from synaptosomes of Torpedo electric organ (1987) (51)
Excitatory Amino Acid Receptors and Depolarization‐Induced Ca2+ Influx into Hippocampal Slices (1987) (49)
The neuronal survival effects of rasagiline and deprenyl on fetal human and rat ventral mesencephalic neurones in culture (2000) (49)
Glutaminase inhibition and the release of neurotransmitter glutamate from synaptosomes (1989) (48)
Depolarisation-induced changes in muscarinic cholinergic receptors in synaptosomes (1979) (48)
The differentiation potential of human foetal neuronal progenitor cells in vitro. (2004) (47)
Inhibitory effects of noradrenaline and dopamine on calcium influx and neurotransmitter glutamate release in mammalian brain slices. (1987) (47)
N‐Methyl‐d‐Aspartate Releases γ‐Aminobutyric Acid from Rat Striatum In Vivo: A Microdialysis Study Using a Novel Preloading Method (1993) (47)
Convulsions and activation of epileptic foci induced by monosodium glutamate and related compounds. (1977) (47)
Induction of Dopaminergic Neurotransmitter Phenotype in Rat Embryonic ‐Cerebrocortex by the Synergistic Action of Neurotrophins and Dopamine (1996) (46)
STIMULATED INCORPORATION OF AMINO ACIDS INTO PROTEINS OF SYNAPTOSOMAL FRACTIONS INDUCED BY DEPOLARIZING TREATMENTS (1977) (45)
The influence of strychnine-insensitive glycine receptor agonists and antagonists on generalized seizure thresholds (1991) (45)
GLUCOSE AND AMINO ACID METABOLISM IN SOME INVERTEBRATE NERVOUS SYSTEMS (1969) (45)
Brain-derived neurotrophic factor in human platelets. (1997) (44)
Parallel induction of the formation of dopamine and its metabolites with induction of tyrosine hydroxylase expression in foetal rat and human cerebral cortical cells by brain-derived neurotrophic factor and glial-cell derived neurotrophic factor. (2001) (42)
Influence of BDNF on the expression of the dopaminergic phenotype of tissue used for brain transplants. (1997) (41)
The depolarisation-induced release of [125I]BDNF from brain tissue (1996) (41)
Chemical neurobiology : an introduction to neurochemistry (1986) (40)
7-Chlorokynurenic acid, a strychnine-insensitive glycine receptor antagonist, inhibits limbic seizure kindling (1990) (39)
The Suppression of Stimulus‐Evoked Release of Amino Acid Neurotransmitters from Synaptosomes by Verapamil (1983) (38)
Neurotransmitter Interaction and Compartmentation (1982) (37)
Amygdaloid kindling by repeated focal N-methyl-D-aspartate administration: comparison with electrical kindling. (1995) (36)
Dopamine Inhibition of the Release of Endogenous Acetylcholine from Corpus Striatum and Cerebral Cortex in Tissue Slices and Synaptosomes: A Presynaptic Response? (1982) (36)
A STUDY OF THE METABOLISM AND RELEASE OF DOPAMINE AND AMINO ACIDS FROM NERVE ENDINGS ISOLATED FROM SHEEP CORPUS STRIATUM (1976) (35)
Ionic accumulation and membrane properties of enriched preparation of neurons and glia from mammalian cerebral cortex (1967) (35)
Effects of anticonvulsants on the in vivo and in vitro release of GABA. (1981) (32)
Glutamine as a Metabolic Substrate for Isolated Nerve-Endings: Inhibition by Ammonium Ions (1975) (32)
Enhancement of depolarization-induced synaptosomal calcium uptake and neurotransmitter release by Bay K8644. (1986) (31)
Observations on the morphology of mammalian synaptosomes following their incubation and electrical stimulation. (1971) (31)
The action of γ-vinyl-GABA and γ-acetylenic-GABA on the resting and stimulated release of GABA in vivo (1980) (31)
Morphine inhibition of calcium fluxes, neurotransmitter release and protein and lipid phosphorylation in brain slices and synaptosomes. (1986) (30)
The protective effect of 2-chloroadenosine against the development of amygdala kindling and on amygdala-kindled seizures. (1997) (29)
Release of amino acids from the chronically‐superfused mammalian cerebral cortex (1974) (29)
Biochemical and morphological studies of the short and long term survival of isolated nerve-endings (1975) (28)
Biological Sciences: Release of Amino-acids and Neurosecretory Substances after Stimulation of Nerve-endings (Synaptosomes) isolated from the Hypothalamus (1972) (28)
Neurotrophins in the pathogenesis and potential treatment of Parkinson's disease. (1999) (27)
Evidence for specific immunolysis of nerve terminals using antisera against choline acetyltransferase, glutamate decarboxylase and tyrosine hydroxylase (1985) (27)
Actions of β‐Bungarotoxin on Amino Acid Transmitter Release (1980) (26)
Effects of γ-acetylenic GABA and γ-vinyl GABA on synaptosomal release and uptake of GABA (1981) (25)
Metabotropic glutamate receptors in the control of neuronal activity and as targets for development of anti-epileptogenic drugs. (2009) (25)
Forskolin-induced expression of tyrosine hydroxylase in human foetal brain cortex. (1999) (24)
THE INFLUENCE OF SODIUM, POTASSIUM AND LANTHANUM ON AMINO ACID RELEASE FROM SPINAL–MEDULLARY SYNAPTOSOMES (1975) (24)
The control of [125I]BDNF release from striatal rat brain slices (2003) (24)
Nerve growth factors and the control of neurotransmitter phenotype selection in the mammalian central nervous system (1997) (23)
Peripheral sensory stimulation and the release of transmitter amino acids in vivo from specific regions of cerebral cortex (1979) (23)
On the Metabolic and Intrasynaptic Origin of Amino Acid Transmitters (1978) (22)
The relationship between complex vesicles, dense-cored vesicles and dense projections in cortical synaptosomes. (1971) (22)
Constituents of a microsomal fraction from the mammalian brain: their solubilization, especially by detergents. (1964) (22)
Lysis of cholinergic synaptosomes by an antiserum to choline acetyltransferase (1982) (21)
Actions of a tremorgenic mycotoxin on amino acid transmitter release in vivo. (1982) (20)
A cell-surface antigen of cholinergic nerve terminals recognized by antisera to choline acetyltransferase (1986) (20)
On the specificity of verapamil as a calcium channel-blocker (1985) (20)
Induction of tyrosine hydroxylase gene expression in human foetal cerebral cortex (1998) (20)
THE DISTRIBUTION OF CATION‐STIMULATED ADENOSINE TRIPHOSPHATASE IN SUB‐CELLULAR FRACTIONS FROM BOVINE CEREBRAL CORTEX (1966) (20)
Factors involved in the determination of the neurotransmitter phenotype of developing neurons of the CNS: Applications in cell replacement treatment for Parkinson's disease (2005) (19)
Comparative effects of benztropine and nomifensine on dopamine uptake and release from striatal synaptosomes. (1981) (19)
A simple semi-automatic apparatus for the purification of amino acids from extracts of tissues and body fluids. (1975) (19)
Metabolic and secretory processes in nerve-endings isolated from post-mortem brain (1979) (19)
The preparation of highly purified GABAergic and cholinergic synaptosomes from mammalian brain (1987) (19)
Effect of Lesions of the Olfactory Bulb on the Levels of Amino Acids and Related Enzymes in the Olfactory Cortex of the Guinea Pig (1984) (19)
Membrane-bound choline acetyltransferase is a cell surface marker of the differentiated NS-20Y cholinergic cell line (1988) (18)
Preloading In Vivo: A Rapid and Reliable Method for Measuring γ‐Aminobutyric Acid and Glutamate Fluxes by Microdialysis (1990) (18)
Participation of intracellular sites in the action of Ca2+ channel blockers. (1986) (17)
Weak anticonvulsant activity of CGP 37849 and CGP 39551 against kindled seizures following systemic administration. (1992) (17)
Striatal extracts promote the survival and phenotypic expression of rat fetal dopaminergic neurons in vitro (2000) (17)
Suppression of evoked and spontaneous release of neurotransmitters in vivo by morphine. (1980) (17)
Autoimmunity to cholinergic‐specific antigens of the brain in senile dementia of the Alzheimer's type (1988) (16)
Actions of Ptychodiscus brevis Red Tide Toxin on Metabolic and Transmitter‐Releasing Properties of Synaptosomes (1982) (16)
Changes in transmitter release patterns in vitro induced by tremorgenic mycotoxins. (1990) (16)
Excitatory Amino Acids (1986) (16)
Absence of an effect of histamine, noradrenaline and depolarizing agents on the levels of adenosine 3', 5'-monophosphate in nerve endings isolated from cerebral cortex. (1974) (15)
UPTAKE AND RELEASE OF TAURINE FROM CEREBRAL CORTEX SLICES AND THEIR SUBCELLULAR COMPARTMENTS (1979) (14)
Handbook of Psychopharmacology, Volume 3: Biochemistry of Biogenic Amines (1977) (14)
Choline acetyltransferase in mammalian synaptosomes: Evidence for an integral membrane-bound form (1988) (14)
Development of Transmitter‐Releasing Capacity in Neuron‐Enriched Tissue Cultures (1987) (14)
Specific lysis of GABAergic synaptosomes by an antiserum to glutamate decarboxylase (1983) (14)
The effects of focal N-methyl-D-aspartate pretreatment on the parameters of amygdaloid electrical kindling. (1997) (13)
Differential Transmitter Release from Nerve Terminals Isolated from Basal Ganglia and Substantia Nigra (1980) (12)
A method for the continuous, long term superfusion of the cerebral cortex of unanaesthetized, unrestrained rats. (1974) (12)
Specific immunolysis of serotonergic nerve terminals using an antiserum against tryptophan hydroxylase (1985) (12)
Effect of tityus toxin and sensory stimulation on muscarinic cholinergic receptors in vivo. (1981) (12)
Competitive NMDA receptor antagonists raise electrically kindled generalized seizure thresholds (1992) (11)
Cultured human foetal cerebral cortex, transfected with tyrosine hydroxylase cDNA, as a source of neural transplant material (2001) (10)
Isolation of Monoaminergic Synaptosomes from Rat Brain by Immunomagnetophoresis (1991) (10)
Brain glutaminase activity in relation to transmitter glutamate biosynthesis (1982) (10)
Specific lysis of noradrenergic synaptosomes by an antiserum to dopamine‐β‐hydroxylase (1986) (10)
Morphine suppression of neurotransmitter release evoked by sensory stimulation in vivo. (1982) (10)
Modulation of Dopamine Release from Neuron‐Enriched Tissue Cultures by Cholinergic Agents (1987) (10)
Uptake studies of taurine in vivo and its effects on the course of experimental focal epilepsy in rats (1977) (10)
Effect of glutamate dimethyl ester and glutamate diethyl ester in delaying the onset of convulsions induced by pentylenetetrazol and strychnine. (1982) (9)
Lack of effect of focally administered prostaglandins on electrically kindled seizure activity. (1991) (9)
Antibodies in Serum of Patients with Alzheimer's Disease Cause Immunolysis of Cholinergic Nerve Terminals from the Rat Cerebral Cortex (1989) (9)
A superfusion system for long-term studies on cerebral cortex in vivo. (1976) (9)
EVIDENCE FOR AN INHIBITORY PRESYNAPTIC COMPONENT OF NEUROLEPTIC DRUG ACTION (1981) (8)
The presence of neuropeptides in GABAergic and cholinergic rat cerebrocortical synaptosome sub-populations (1992) (8)
Responses of synaptosomes to electrical stimulation. (1970) (7)
Effect of β‐Bungarotoxin on the Release of Endogenous Amino Acids from the Sensorimotor Cortex (1981) (7)
Prostaglandins D2 and E2 are not regulators of amino acid release from rat cortical synaptosomes. (1982) (7)
In vivo release of acetylcholine evoked by brachial plexus stimulation and tityustoxin. (1980) (7)
The action of gamma-vinyl-GABA and gamma-acetylenic-GABA on the resting and stimulated release of GABA in vivo. (1980) (7)
The properties of cultured fetal human and rat brain tissue and its use as grafts for the relief of the Parkinsonian syndrome (1992) (7)
EFFECT OF SENSORY STIMULATION ON AMINO ACID INCORPORATION INTO BRAIN PROTEINS IN VIVO (1979) (6)
Effect of Stimulation on the Incorporation of 14C from Glial and Neuronal Specific Substrates into Brain Proteins In Vivo and In Vitro (1980) (6)
Acetylcholine release and muscarinic receptors in cortical synaptosomes from epileptic rats (1981) (6)
The metabolism of glucose 6-phosphate by mammalian cerebral cortex in vitro. (1971) (6)
The anti-epileptic effect of 3-aminopropylarsonate on electrically-kindled and N-methyl-d-aspartate-kindled amygdala (1996) (6)
Neural toxicity of retroviruses (1996) (6)
The immunolysis, isolation, and properties of subpopulations of mammalian brain synaptosomes (1989) (5)
Sites of action of Ca2+-channel blockers in rat cortical synaptosomes (1985) (5)
Synaptic Preparations for Studying Neurotransmission at the Biochemical Level (1974) (5)
Treatment of Experimental Epilepsy with Taurine (1974) (5)
Changes in protein synthesis in cortical subcellular fractions after activation of the brachial plexus [proceedings]. (1980) (5)
Characterisation of N-methyl-D-aspartate (NMDA)-induced kindling. (1996) (4)
The release of endogenous 3,4-dihydroxyphenethylamine from synaptosomes isolated from corpus striatum,. (1975) (4)
METABOLISM OF NERVE-ENDING PARTICLES (1969) (4)
The use of foetal human brain tissue as brain implants: phenotype manipulation by genetic manipulation and biochemical induction. (2002) (4)
Effects of gamma-acetylenic GABA and gamma-vinyl GABA on synaptosomal release and uptake of GABA. (1981) (4)
Peripheral sensory stimulation and the release of transmitter amino acids in vivo from specific regions of cerebral cortex. (1979) (4)
Uptake and Stimulated Release of Taurine by Preparations of Cerebral Cortex (1981) (4)
Inhibition of depolarization‐coupled calcium fluxes and transmitter release in vitro by morphine (1982) (4)
Relative anticonvulsant potencies of CPP and some novel analogues in the kindled rat. (1993) (4)
Choline acetyltransferase may be a cell-surface marker of the cholinergic NS-20Y cell line (1986) (3)
The Detection, Isolation and Properties of Sub-Populations of Mammalian Brain Synaptosomes of Defined Neurotransmitter Type (1988) (3)
Membrane-bound glutamate decarboxylase may be present in synaptic plasma membranes as an integral membrane protein (1988) (3)
Transport of amino acids and catecholamines in relation to metabolism and transmission. (1976) (3)
Compartmentation of synaptosomal dopamine. (1978) (3)
Kinetic properties of glutaminase from cerebral cortex (1984) (3)
A scientific odyssey: an appreciation of Albert Szent-Györgyi (1987) (3)
Book Review:Aromatic Amino Acids in the Brain. G. E. W. Wolstenholme, David W. Fitzsimons (1975) (2)
Synaptosome beds: a method for the study in vitro of the metabolism and function of nerve endings. (1972) (2)
Evoked dopamine release in primary brain tissue culture (1985) (2)
Neuropeptide content of purified rat brain cholinergic synaptosome subpopulations (1992) (2)
Glutamate as a neurotransmitter in the cortico-striate pathway: evidence in vivo (1986) (2)
On the specificity of verapamil as a calcium channel-blocker. (1986) (2)
GABA Release in Vivo and in Vitro: Responses to Physiological and Chemical Stimuli (1981) (2)
Handbook of Psychopharmacology, Volume 4: Amino Acid Neurotransmitters (1977) (2)
In Vivo Inhibition of Incorporation of [U‐14U]Glucose into Proteins in Experimental Focal Epilepsy (1982) (2)
Chloride ions influence the equilibrium of choline acetyltransferase between the membrane-bound integral form and the soluble form (1987) (1)
The effect of 2-amino-3-arsonopropionate and 2-amino-4-arsonobutyrate on the development and maintenance of amygdala kindled seizures. (1998) (1)
Isolation of highly purified cholinergic and GABAergic synaptosomes from mammalian brain using an immunomagnetophoretic technique (1987) (1)
Isolation of catecholaminergic synaptosomes from mammalian brain (1989) (1)
N-Methyl-d-aspartate antagonists inhibit Ca2+ influx into hippocampal slices stimulated by depolarizing agents and by excitatory amino acids (1986) (1)
A role for NMDA receptors in epileptogenesis (1987) (1)
The action of neurotransmitters on the uptake of 45Ca2+ and the release of neuroactive amino acids from mammalian brain slices (1986) (1)
Stimulation of GABAA receptors in mammalian synaptosomes causes amino acid neurotransmitter release (1987) (1)
Presynaptic factors preconditioning synaptic activity. (1978) (0)
Cultured human foetal cerebral cortex lipo-transfected with tyrosine hydroxylase cDNA as a source of neuronal transplant tissue (2001) (0)
Neurochemistry: A practical approach : Edited by A.J. Turner and H.S. Bachelard IRL Press; Oxford, Washington, 1987 277 pages. £17.00, $32.00 (paperback) (1988) (0)
Purinergic Receptors: Volume 12, Series B: Receptors and Recognition (1982) (0)
Effect of beta-bungarotoxin on the release of endogenous amino aids from the sensorimotor cortex. (1981) (0)
A chamber for maintaining isolated mammalian nervous tissue during electrical recording (1967) (0)
Various in the vulne rability of rat retinal neurons submithed to ischemia: involvement of excitatary amino acids (1992) (0)
EVIDENCE FOR AN INHIBITORYPRESYNAPTICCOMPONENT OF NEUROLEPTICDRUG ACTION (1981) (0)
Book Review:Protein Metabolism of the Brain. A. V. Palladin, Ya V. Belik, N. M. Polyakova, Basil Haigh (1978) (0)
Release of corticotrophin-releasing factor (CRF) following the electrical stimulation of nerve-endings isolated from the sheep hypothalamus. (1972) (0)
Neurochemical and synaptic mechanisms underlying epilepsy : A current hypothesis (1996) (0)
Uptake of opioid drugs by rat cerebrocortical brain slices. (1986) (0)
Aromatic Amino Acid Hydroxylases and Mental Disease (1980) (0)
Specific immunolysis of synaptosomes using antisera against choline acetyltransferase, glutamate decarboxylase and tyrosine hydroxylase (1985) (0)
Inhibition of depolarization-coupled Ca2+ fluxes and transmitter release in vitro by morphine (1982) (0)
Release of corticotrophin releasing factor (CRF) following the electrical stimulation of nerve endings isolated from the sheep hypothalamus. (1972) (0)
Effect of Depolarizing Agents on the Incorporation of Amino Acids into Soluble Cytoplasmic and Membrane‐Bound Proteins of Synaptosome Fractions (1981) (0)
Actions of beta-bungarotoxin on amino acid transmitter release. (1980) (0)
Book reviewThe release of catecholamines from adrenergic neurons: Edited by David M. Paton. Pp. 393. Pergamon Press, Oxford. 1979. Hard cover £20.00, flexi cover £10.00 (1980) (0)
Neurotrophins in the pathogenesis and neurosurgical treatment of Parkinson's disease (1999) (0)
Kainate potentiates excitatory amino acid release in striatum (1987) (0)
Biochemistry and neurology : proceedings of a conference organized by the Neurochemical Group of the Biochemical Society and held at Nottingham University, April 1975 (1976) (0)
The differential release of amino acids and neuropeptides from purified subpopulations of mammalian GABAergic and cholinergic cerebrocortical synaptosomes (1993) (0)
Formation of glucose from glucose 6-phosphate by rat brain slices. (1972) (0)
Cultured human fetal and rat brain tissue and Parkinson's disease (1992) (0)
Rabbit eye model of neural ischaemia: applications and advantages (1992) (0)

This paper list is powered by the following services:

Harry F. Bradford's Academic­Influence.com Rankings

Why Is Harry F. Bradford Influential?

Harry F. Bradford's Published Works

Published Works

Harry F. Bradford's AcademicInfluence.com Rankings